Choosing stem cell culture media you will not have to change later: why a stem cell growth medium chosen for convenience becomes a comparability problem the moment a programme moves toward the clinic, how cell growth media and cell culture media formulations are compared once defined and serum free composition is separated from what is left to the coating, where organoid culture media impose a matrix dependence of their own, how stem cell reagents and the other research reagents beyond the medium decide whether a line stays undifferentiated, where gmp cell culture media differ from research grade in documentation rather than in composition, and what to record about medium lots so a drift can be investigated

Medium is the most consequential consumable in a cell culture laboratory and the one most often chosen by inheritance. Undefined components vary between lots, coatings interact with formulations, and a medium change part way through a programme creates a comparability problem that is expensive to answer. This page is about choosing once.

the ICH guideline on characterisation of cell substrates
Q5D
current good manufacturing practice for finished pharmaceuticals, 21 CFR
Part 211
the biosafety manual that decides handling for cultured material
BMBL

The figures in this panel are guideline and regulation identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a media price index it has not measured.

Choosing and controlling medium

  1. Prefer defined formulations where the work allows. A defined, serum free medium removes the largest source of lot to lot variation and makes results comparable over years. Where serum is unavoidable, reserve lots and test them before committing.
  2. Treat the coating as part of the medium system. Formulations are developed with a particular attachment substrate, and swapping the coating changes behaviour even when the medium is unchanged. Validate the pair together, not separately.
  3. Reserve lots for the length of a study. Ask the supplier to hold a lot, and buy enough of it to complete the study. A medium lot change mid study is a variable that cannot be removed from the analysis afterwards.
  4. Plan the transition to a graded medium early. Moving to a manufacturing grade formulation changes documentation, supply terms and sometimes composition. Making that change while cells are already committed to a programme is far harder than making it at the start.
  5. Record the lot with every experiment. A medium lot number in the experimental record is what makes a later drift investigable. Without it, a change in behaviour has no candidate explanation to test.
  6. Confirm the phenotype, not just the growth. Cells can grow well in a medium that quietly permits differentiation or drift. Check the markers that define the state on a schedule rather than assuming healthy morphology means an unchanged population.

The medium change nobody planned

Suppliers reformulate, discontinue and change manufacturing sites, and the notice period is often short. A laboratory whose results depend on one formulation with no alternative validated is exposed to a decision it does not control.

Qualify a second formulation before you need it, even if you never use it. The comparability data is far cheaper to generate while the first medium is still available.

What to write down

Medium name and catalogue number, lot, supplement lots, coating and its lot, passage number, and the date. Those seven fields turn an unexplained change in behaviour into a short investigation.

Most laboratories record the first two. The value is in the rest, and in recording them consistently enough that a comparison across months is possible.

Common questions

Is serum free always better?
For consistency and for anything heading toward the clinic, yes. For some primary and specialised cells, serum containing formulations remain the only ones that work, in which case lot testing and reservation become essential.
Why did cells change behaviour on a new medium lot?
Undefined components vary, and coatings and growth factors degrade at different rates. This is the reason to reserve lots and to record lot numbers, because otherwise there is nothing to compare against.
What makes a medium GMP grade?
Manufacture under a quality system with controlled raw materials, documented processes, release testing and traceability, plus supply terms that support a regulated process. The formulation may be identical to the research version.
How often should the phenotype be checked?
On a schedule set by how quickly the population drifts, and always before a critical experiment. Marker checks are cheap next to a study built on cells that were no longer what they were assumed to be.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/stem-cell-culture-media/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices